购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • Drug Metabolite
    (1)
  • PPAR
    (1)
  • Others
    (1)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (1)
  • 5日内发货
    (1)
  • 35日内发货
    (2)
  • 6-8周
    (1)
抑制剂&激动剂
细分筛选
搜索结果
TargetMol产品目录中 "clofibric acid"的结果
筛选
搜索结果
TargetMol产品目录中 "

clofibric acid

"的结果
  • 抑制剂&激动剂
    5
    TargetMol | Inhibitors_Agonists
  • 同位素
    2
    TargetMol | Isotope_Products
  • Clofibric acid
    氯贝酸, Chlorofibrinic acid
    T0061882-09-7
    Clofibric acid (Chlorofibrinic acid) 是一种脂质纤维调节剂 Clofibrate,Etofibrate 和 Etofyllinclofibrate 的活性代谢物,是 PPARα的激动剂,具有降血脂作用,也可作为除草剂。
    • ¥ 163
    In stock
    规格
    数量
  • Clofibric Acid-d4
    T713051184991-14-7
    Clofibric acid-d4 is intended for use as an internal standard for the quantification of clofibric acid by GC- or LC-MS. Clofibric acid is a peroxisome proliferator-activated receptor α (PPARα) agonist (EC50 = 50 µM in a transactivation assay) and the active metabolite of clofibrate. It is formed from clofibrate by tissue and serum esterases. Dietary administration of clofibric acid (0.067-0.22%) reduces serum cholesterol, phospholipid, and triglyceride levels in rats. It decreases glutamate oxaloacetate transaminase (GOT) levels and increases glutamate pyruvate transaminase (GPT) and lactate dehydrogenase (LDH) levels, markers of xenobiotic stress, in the plasma of carp (C. carpio) when administered in tank water at a concentration of 10 µg L. Clofibric acid has been found in wastewater effluent.
    • 待估
    35日内发货
    规格
    数量
  • Tocofibrate
    TOCOPHERYL 2-(P-CHLOROPHENOXY) ISOBUTYRATE, TOCOFEROL-2-(P-CHLOROPHENOXY)-2-METHYLPROPIONATE
    T20251950465-39-9
    Tocofibrate是一种包含氯贝酸和α-生育酚的过氧化物诱导性酯类化合物。
    • 待询
    10-14周
    规格
    数量
  • Aluminium clofibrate
    Atherolip,Alfibrate,Alufibrate
    T2124324818-79-9
    Aluminium clofibrate, a salt of clofibric acid, is a peroxisome proliferator.
    • ¥ 10600
    6-8周
    规格
    数量
  • Gliclazide-d4
    T719811185039-30-8
    Gliclazide-d4 is intended for use as an internal standard for the quantification of gliclazide by GC- or LC-MS. Gliclazide is a sulfonylurea and an inhibitor of pancreatic β-cell ATP-sensitive potassium (KATP) channels. It is selective for pancreatic β-cell over cardiac and arterial smooth muscle cell KATP channels. Gliclazide (5 μM) increases insulin-induced glucose uptake and glucose transporter 4 (GLUT4) translocation to the plasma membrane in a differentiated 3T3L1 adipocyte model of insulin resistance induced by hydrogen peroxide. Gliclazide (5 and 10 μg ml) reduces LDL oxidation by human aortic smooth muscle cells (HASMCs), decreasing TBARS content and 8-isoprostane levels. It also decreases oxidized LDL-induced HASMC proliferation and monocyte adhesion when used at concentrations ranging from 1 to 10 μg ml. Gliclazide (5 mg kg) reduces serum glucose levels and increases glucose uptake by isolated rat hindquarters in a model of diabetes induced by streptozotocin (STZ).
    • 待估
    35日内发货
    规格
    数量